Clinical trial
Cerebral Amyloid Imaging Using Florbetapir (18F-AV-45) for the Etiological Diagnosis of Poststroke Cognitive Impairment and Dementia
NCT02813434 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cerebral Amyloid Imaging Using Florbetapir (18F-AV-45) for the Etiological Diagnosis of Poststroke Cognitive Impairment and Dementia
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 24, 2014
- Completion date
- January 7, 2025
- Enrollment
- 92 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.